Meridian's C. Difficile MDx Assay Receives FDA Clearance

The illumigene C. difficile molecular amplification test is Meridian's first molecular diagnostic product.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories